Vetter H, Siebenschein R, Studer A, Witassek F, Furrer J, Glänzer K, Siegenthaler W, Vetter W
Acta Endocrinol (Copenh). 1978 Dec;89(4):710-25. doi: 10.1530/acta.0.0890710.
In 31 patients with primary aldosteronism routine clinical and laboratory data, the effect of orthostasis on plasma aldosterone (PA), plasma renin activity (PRA) and cortisol (PC), effect of fludrocortisone or high sodium intake on basal PA and night-day fluctuations of basal PA and PC with and without suppression of pituitary ACTH by dexamethasone were determined to differentiate patients with a unilateral aldosterone producing tumour (adenoma, APA, n=20; carcinoma, CA, n=1) from those with idiopathic bilateral adrenal hyperplasia (IAH, n=10). Mean systolic and diastolic blood pressure, age, serum potassium and urinary excretion of sodium and potassium were not significantly different in both groups of patients. Normokalaemic primary aldosteronism occurred both in patients with APA (n=2) and in patients with IAH (n=1). Mean basal PA and mean urinary excretion rate of aldosterone-18-glucuronide were higher though not significantly different in patients with APA or CA than in those with IAH. A substantial number of the patients with APA (n=5) and with IAH (n=3) showed urinary excretion rates of aldosterone-18-glucuronide less than 13 microgram/24 h. Mean PA and PRA significantly increased (P less than 0.025) in patients with IAH in response to posture. However, these changes also occurred at times in some patients with APA. Both fludrocortisone and high sodium intake produced a variable and no group-specific effect on basal PA. Night-day variations in PA were positively correlated with those in PC in all patients with APA (n=12) and in 5 of 8 patients with IAH. A dissociation of PA and PC, however, was only observed in patients with IAH. Finally, the effect of dexamethasone on plasma aldosterone curves was variable in both groups of patients. Our results indicate that under the described conditions analysis of routine clinical and laboratory data and of peripheral PA, PRA and PC are of limited value in differentiating patients with APA or CA from those with IAH.
在31例原发性醛固酮增多症患者中,测定了常规临床和实验室数据、立位对血浆醛固酮(PA)、血浆肾素活性(PRA)和皮质醇(PC)的影响、氟氢可的松或高钠摄入对基础PA的影响以及基础PA和PC在有或无地塞米松抑制垂体促肾上腺皮质激素(ACTH)情况下的昼夜波动,以区分单侧醛固酮分泌瘤(腺瘤,APA,n = 20;癌,CA,n = 1)患者与特发性双侧肾上腺增生(IAH,n = 10)患者。两组患者的平均收缩压和舒张压、年龄、血清钾以及钠和钾的尿排泄量无显著差异。正常血钾性原发性醛固酮增多症在APA患者(n = 2)和IAH患者(n = 1)中均有发生。APA或CA患者的平均基础PA和醛固酮 - 18 - 葡萄糖醛酸苷的平均尿排泄率虽高于IAH患者,但无显著差异。相当数量的APA患者(n = 5)和IAH患者(n = 3)的醛固酮 - 18 - 葡萄糖醛酸苷尿排泄率低于13微克/24小时。IAH患者的平均PA和PRA因体位变化而显著升高(P < 0.025)。然而,这些变化在某些APA患者中有时也会出现。氟氢可的松和高钠摄入对基础PA均产生可变且无组特异性的影响。在所有APA患者(n = 12)和8例IAH患者中的5例中,PA的昼夜变化与PC的昼夜变化呈正相关。然而,仅在IAH患者中观察到PA和PC的分离。最后,地塞米松对两组患者血浆醛固酮曲线的影响是可变的。我们的结果表明,在所述条件下,分析常规临床和实验室数据以及外周PA、PRA和PC在区分APA或CA患者与IAH患者方面价值有限。